Caries Removal in Primary Teeth Using Er:YAG Laser
Launched by KING ABDULAZIZ UNIVERSITY · Jun 17, 2023
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
Study Design: A randomized, blinded split-mouth study was conducted with a sample of 40 healthy children aged 9 to 12 years (N=40 children) / (n=80 teeth). The children were divided into two groups randomly. The first group included 20 children who were assigned to receive the conventional treatment at the first visit and the laser treatment at the second visit (N=20 children) / (n=40 teeth). The second group was assigned to receive the laser treatment at the first visit and the conventional treatment at the second visit (N=20 children) / (n=40 teeth). Both groups received the laser and con...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy patients between 9 and 12 years of age.
- • Simple occlusal caries that is limited to enamel and dentine without proximal caries, or pulp involvement in at least two primary molars (pairs).
- • Primary molars with 1/3rd of their root remained.
- • Primary teeth have permanent successor teeth with 1/2 of the root formed.
- Exclusion Criteria:
- • Caries lesion that had reached or was approaching the pulp.
- • Previous fillings.
- • Periapical lesions, or dental abscess.
- • No permanent successor teeth.
- • Behavioral or medical problem.
About King Abdulaziz University
King Abdulaziz University (KAU) is a leading academic institution located in Jeddah, Saudi Arabia, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, KAU leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving healthcare outcomes. The university fosters collaboration among multidisciplinary teams of researchers, clinicians, and industry partners, ensuring adherence to rigorous ethical standards and regulatory requirements. KAU is dedicated to enhancing scientific knowledge and translating research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jeddah, , Saudi Arabia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported